Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma? - PubMed (original) (raw)
Review
. 2011 Jun;1807(6):552-61.
doi: 10.1016/j.bbabio.2010.10.012. Epub 2010 Oct 16.
Affiliations
- PMID: 20955683
- DOI: 10.1016/j.bbabio.2010.10.012
Free article
Review
Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma?
Caroline Jose et al. Biochim Biophys Acta. 2011 Jun.
Free article
Abstract
A considerable amount of knowledge has been produced during the last five years on the bioenergetics of cancer cells, leading to a better understanding of the regulation of energy metabolism during oncogenesis, or in adverse conditions of energy substrate intermittent deprivation. The general enhancement of the glycolytic machinery in various cancer cell lines is well described and recent analyses give a better view of the changes in mitochondrial oxidative phosphorylation during oncogenesis. While some studies demonstrate a reduction of oxidative phosphorylation (OXPHOS) capacity in different types of cancer cells, other investigations revealed contradictory modifications with the upregulation of OXPHOS components and a larger dependency of cancer cells on oxidative energy substrates for anabolism and energy production. This apparent conflictual picture is explained by differences in tumor size, hypoxia, and the sequence of oncogenes activated. The role of p53, C-MYC, Oct and RAS on the control of mitochondrial respiration and glutamine utilization has been explained recently on artificial models of tumorigenesis. Likewise, the generation of induced pluripotent stem cells from oncogene activation also showed the role of C-MYC and Oct in the regulation of mitochondrial biogenesis and ROS generation. In this review article we put emphasis on the description of various bioenergetic types of tumors, from exclusively glycolytic to mainly OXPHOS, and the modulation of both the metabolic apparatus and the modalities of energy substrate utilization according to tumor stage, serial oncogene activation and associated or not fluctuating microenvironmental substrate conditions. We conclude on the importance of a dynamic view of tumor bioenergetics.
Copyright © 2010 Elsevier B.V. All rights reserved.
Similar articles
- A pivotal role for p53: balancing aerobic respiration and glycolysis.
Ma W, Sung HJ, Park JY, Matoba S, Hwang PM. Ma W, et al. J Bioenerg Biomembr. 2007 Jun;39(3):243-6. doi: 10.1007/s10863-007-9083-0. J Bioenerg Biomembr. 2007. PMID: 17551815 Review. - Availability of the key metabolic substrates dictates the respiratory response of cancer cells to the mitochondrial uncoupling.
Zhdanov AV, Waters AH, Golubeva AV, Dmitriev RI, Papkovsky DB. Zhdanov AV, et al. Biochim Biophys Acta. 2014 Jan;1837(1):51-62. doi: 10.1016/j.bbabio.2013.07.008. Epub 2013 Jul 23. Biochim Biophys Acta. 2014. PMID: 23891695 - Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells.
Smolková K, Plecitá-Hlavatá L, Bellance N, Benard G, Rossignol R, Ježek P. Smolková K, et al. Int J Biochem Cell Biol. 2011 Jul;43(7):950-68. doi: 10.1016/j.biocel.2010.05.003. Epub 2010 May 10. Int J Biochem Cell Biol. 2011. PMID: 20460169 Review. - Oxidative metabolism in cancer growth.
Ristow M. Ristow M. Curr Opin Clin Nutr Metab Care. 2006 Jul;9(4):339-45. doi: 10.1097/01.mco.0000232892.43921.98. Curr Opin Clin Nutr Metab Care. 2006. PMID: 16778561 Review. - Bioenergetics of lung tumors: alteration of mitochondrial biogenesis and respiratory capacity.
Bellance N, Benard G, Furt F, Begueret H, Smolková K, Passerieux E, Delage JP, Baste JM, Moreau P, Rossignol R. Bellance N, et al. Int J Biochem Cell Biol. 2009 Dec;41(12):2566-77. doi: 10.1016/j.biocel.2009.08.012. Epub 2009 Aug 25. Int J Biochem Cell Biol. 2009. PMID: 19712747
Cited by
- Withaferin A decreases glycolytic reprogramming in breast cancer.
Khan A, Rehman AU, Siddiqui S, Khan J, Massey S, Singh P, Saluja D, Husain SA, Iqbal MA. Khan A, et al. Sci Rep. 2024 Oct 4;14(1):23147. doi: 10.1038/s41598-024-72221-5. Sci Rep. 2024. PMID: 39366987 Free PMC article. - Non-coding RNAs as potential targets in metformin therapy for cancer.
Zhang Y, Wu Y, Liu Z, Yang K, Lin H, Xiong K. Zhang Y, et al. Cancer Cell Int. 2024 Oct 1;24(1):333. doi: 10.1186/s12935-024-03516-w. Cancer Cell Int. 2024. PMID: 39354464 Free PMC article. Review. - The critical role of glutamine and fatty acids in the metabolic reprogramming of _anoikis_-resistant melanoma cells.
Peppicelli S, Kersikla T, Menegazzi G, Andreucci E, Ruzzolini J, Nediani C, Bianchini F, Calorini L. Peppicelli S, et al. Front Pharmacol. 2024 Aug 8;15:1422281. doi: 10.3389/fphar.2024.1422281. eCollection 2024. Front Pharmacol. 2024. PMID: 39175551 Free PMC article. - Endometriotic lesions exhibit distinct metabolic signature compared to paired eutopic endometrium at the single-cell level.
Sarsenova M, Lawarde A, Pathare ADS, Saare M, Modhukur V, Soplepmann P, Terasmaa A, Käämbre T, Gemzell-Danielsson K, Lalitkumar PGL, Salumets A, Peters M. Sarsenova M, et al. Commun Biol. 2024 Aug 21;7(1):1026. doi: 10.1038/s42003-024-06713-5. Commun Biol. 2024. PMID: 39169201 Free PMC article. - Dependence on mitochondrial respiration of malignant T cells reveals a new therapeutic target for angioimmunoblastic T-cell lymphoma.
Krug A, Mhaidly R, Tosolini M, Mondragon L, Tari G, Turtos AM, Paul-Bellon R, Asnafi V, Marchetti S, Di Mascio L, Travert M, Bost F, Bachy E, Argüello RJ, Fournié JJ, Gaulard P, Lemonnier F, Ricci JE, Verhoeyen E. Krug A, et al. Cell Death Discov. 2024 Jun 19;10(1):292. doi: 10.1038/s41420-024-02061-9. Cell Death Discov. 2024. PMID: 38897995 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous